Toufike Kanouni

Associate Scientist at Takeda San Diego, Inc.
Research

Experience

Associate Scientist
Takeda San Diego, Inc.
Public Company; Pharmaceuticals
May 2011 - Present

Senior Research Associate II
Takeda San Diego, Inc.
Public Company; Pharmaceuticals
August 2010 - May 2011

Research Scientist, exchange program with Takeda Japan (Osaka)
Takeda Pharmaceuticals
Public Company; Pharmaceuticals
April 2008 - April 2009

Senior Research Associate I, Chemistry
TAKEDASD
Research
March 2006 - August 2010

RA II chemistry
Structural Genomix
51-200 employees; Privately Held; Research
March 2003 - March 2006

Education

Universit Louis Pasteur (Strasbourg I)

Patents (7)

Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK
Qing Dong, Toufike Kanouni, John David Lawson, Michael B Wallace
April 16, 2013: 08420816

MAPK/ERK kinase inhibitors (1 worldwide citation)
Qing Dong, Toufike Kanouni, Michael B Wallace
September 20, 2011: 08022057

Dihydropyrrolonaphtyridinone compounds as inhibitors of jak
Qing Dong, Toufike Kanouni, John David Lawson, Michael B Wallace
June 9, 2011: 20110136780-A1

MAPK/ERK KINASE INHIBITORS
Qing Dong, Xianchang Gong, Stephen W Kaldor, Toufike Kanouni, Nicholas Scorah, Michael B Wallace, Feng Zhou
May 27, 2010: 20100130518-A1

Mapk/erk kinase inhibitors
MarK Adams, Qing Dong, Toufike Kanouni, Stephen W Kaldor, Nicholas Scorah, Michael B Wallace
May 14, 2009: 20090124595-A1

Mapk/erk kinase inhibitors
Qing Dong, Xianchang Gong, Stephen W Kaldor, Toufike Kanouni, Nicholas Scorah, Michael B Wallace, Feng Zhou
October 16, 2008: 20080255160-A1

Pyrazolothiazole Protein Kinase Modulators
Pierre Yves Bounaud, Stephanie A Hopkins, Elizabeth Anne Jefferson, Mark E Wilson, Melissa S Wong, Toufike Kanouni
July 26, 2007: 20070173488-A1

Connections (80)
Jeffrey Stafford
Chief Scientific Officer at QuantiCell Pharma, Inc.

Stephanie Hopkins
Chemist at Selexagen

Chixu Chen
Principal Scientist II at Ardea Biosciences